Spotlight -

Drug Development|

Quality Systems

|Articles|January 18, 2022

Process Impurities Clearance in Biologics

Author(s)Element

This white paper discusses developing optimal platform analytical methods with partner CDMOs for effective process impurities clearance in biological drug substances.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Related Content

The Role of Continuous Monitoring Systems in Meeting Regulatory Requirements

August 19th 2026

Sponsored Content

Your Checklist for Finding the Right Environmental Monitoring System

August 19th 2026

Sponsored Content

Temperature and Humidity Monitoring: How to Maintain Biopharmaceutical Quality Assurance

August 19th 2026

Sponsored Content

Ensuring Sample Integrity from Discovery to Post-Market Surveillance

August 19th 2026

Sponsored Content

Quality and Regulations eBook July 2026

July 29th 2026

Sponsored Content

Trending on Pharmaceutical Technology

What Does Overton's FDA Nomination Mean for Drug Reviews?

Ask the Expert: Complying with Standards

Ecopipam's D1 Receptor Approach Signals New Pediatric Neuroscience Pathway

GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing

How a 63-Patient Trial Delivered an FDA Approval